Sensei Biotherapeutics In... (SNSE)

0.44

0.01 (2.09%)

At close: Mar 04, 2025, 1:06 PM

Sensei Biotherapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-34.1M	-48.59M	-36.79M	-20.1M	-16.74M	-13.04M
Depreciation & Amortization	1.35M	1.35M	685K	209K	73K	44K
Stock-Based Compensation	4.45M	5.81M	5.66M	1.49M	1.18M	1.19M
Other Working Capital	-2M	-1.01M	1.54M	-732K	1.13M	559K
Other Non-Cash Items	603K	1.4M	57K	2.13M	1.48M	349K
Deferred Income Tax	n/a	n/a	19K	-1.04M	1.97M	n/a
Change in Working Capital	-4.33M	1.01M	117K	-397K	3.47M	1.49M
Operating Cash Flow	-32.02M	-39.03M	-30.26M	-17.7M	-8.57M	-10.31M
Capital Expenditures	-180K	-321K	-2.03M	-1.21M	-53K	-31K
Acquisitions	n/a	15K	318K	-197K	n/a	n/a
Purchase of Investments	-21.15M	-46.87M	-183.67M	n/a	n/a	n/a
Sales Maturities Of Investments	59.58M	97.12M	42.26M	n/a	n/a	n/a
Other Investing Acitivies	166K	50.27K	-141.09K	-197K	n/a	n/a
Investing Cash Flow	38.41M	49.95M	-143.12M	-1.4M	-53K	-31K
Debt Repayment	-761K	-629K	-255K	526K	8.07M	750K
Common Stock Repurchased	-10.38M	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-28K	n/a	23.6M	34.93M	154K	n/a
Financial Cash Flow	-11.17M	-287K	163.94K	35.45M	8.22M	750K
Net Cash Flow	-4.78M	10.64M	-9.44M	16.34M	-402K	-9.59M
Free Cash Flow	-32.2M	-39.35M	-32.28M	-18.91M	-8.62M	-10.34M